• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	41.9525 mg

  ATC: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	83.905 mg

  ATC: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	167.81 mg

  ATC: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	251.715 mg

  ATC: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	335.62 mg

  ATC: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.

• Tadomon

  Form: tablets, prolonged release

  Active substance	Dosage
  tapentadol tartrate	419.525 mg

  ATC: N02AX06

  Manufacturer: G.L. Pharma GmbH Laboratorios Liconsa S.A.